Loss of TGF-beta Receptors in Oral Cancer
Author Information
Author(s): Meng Wenxia, Xia Qingjie, Wu Lanyan, Chen Sixiu, He Xin, Zhang Lin, Gao Qinghong, Zhou Hongmei
Primary Institution: Sichuan University
Hypothesis
The study aims to assess the expression levels of TGF-beta receptors in oral premalignant lesions and oral squamous cell carcinoma.
Conclusion
The study provides evidence that the loss of TGF-beta receptor types II and III expression is common in oral squamous cell carcinoma.
Supporting Evidence
- The expression of TGF-beta receptors decreased with the progression of oral cancer.
- Approximately 35.3% of OSCC specimens showed low or absent expression of TGF-beta receptor II.
- Approximately 52.9% of OSCC specimens showed low or absent expression of TGF-beta receptor III.
- The loss of TGF-beta receptor expression was observed in both oral epithelium and carcinoma-associated fibroblasts.
Takeaway
This study found that important proteins that help control cancer growth are missing in many oral cancer patients, which could help doctors find new ways to treat the disease.
Methodology
The study used immunohistochemical analysis, quantitative RT-PCR, and Western blot to assess receptor expression in tissue samples and cultured fibroblasts.
Participant Demographics
{"age_range":"41-86","sex_distribution":{"male":42,"female":26}}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website